cp 424391 has been researched along with glucagon-like peptide 1 in 1 studies
Studies (cp 424391) | Trials (cp 424391) | Recent Studies (post-2010) (cp 424391) | Studies (glucagon-like peptide 1) | Trials (glucagon-like peptide 1) | Recent Studies (post-2010) (glucagon-like peptide 1) |
---|---|---|---|---|---|
34 | 7 | 20 | 9,484 | 1,208 | 6,374 |
Protein | Taxonomy | cp 424391 (IC50) | glucagon-like peptide 1 (IC50) |
---|---|---|---|
Glucagon-like peptide 1 receptor | Homo sapiens (human) | 0.0051 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Castro, RA; Gilor, C; Hill, RC; O'Kell, AL; Pascutti, KM; Salute, ME | 1 |
1 other study(ies) available for cp 424391 and glucagon-like peptide 1
Article | Year |
---|---|
The effect of capromorelin on glycemic control in healthy dogs.
Topics: Animals; Blood Glucose; Blood Glucose Self-Monitoring; Cats; Dogs; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Glycemic Control; Insulin; Piperidines; Prospective Studies; Pyrazoles | 2022 |